Tiziana Announces Submission of Patent Application on Use of Foralumab July 16, 2020 – Posted in: Tiziana Life Sciences (TILS)

16 July 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”)    Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T Therapy New York/London, July 16, 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, is pleased to announce that it has submitted a…

Continue reading